Source:http://linkedlifedata.com/resource/pubmed/id/11902729
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-3-20
|
pubmed:abstractText |
The vanB gene cluster mediates glycopeptide resistance by production of peptidoglycan precursors ending in the depsipeptide D-alanyl-D-lactate (D-Ala-D-Lac) instead of D-Ala-D-Ala found in susceptible enterococci. Synthesis of D-Ala-D-Lac and hydrolysis of D-Ala-D-Ala is controlled by the VanR(B)S(B) two-component regulatory system that activates transcription of the resistance genes in response to vancomycin but not to teicoplanin. Two substitutions (A3C-->G or D168-->Y) in the VanS(B) sensor kinase resulted in induction by teicoplanin, indicating that the N-terminal domain of the protein was involved in glycopeptide sensing. A substitution (T237-->K) located in the vicinity of the putative autophosphorylation site of VanS(B) (H233) was associated with a constitutive phenotype and affected a conserved residue known to be critical for the phosphatase activity of related kinases. A mutant producing an impaired host D-Ala:D-Ala ligase required vancomycin for growth, since D-Ala-D-Lac was only produced under inducing conditions. The ddl and vanS(B) mutations, alone or in combination, resulted in various resistance phenotypes that were determined by the amount of D-Ala-D-Ala and D-Ala-D-Lac incorporated into peptidoglycan precursors under different inducing conditions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/D-alanylalanine synthetase,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Synthases,
http://linkedlifedata.com/resource/pubmed/chemical/Teicoplanin,
http://linkedlifedata.com/resource/pubmed/chemical/VanB protein, Enterococcus
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0950-382X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
93-105
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11902729-Anti-Bacterial Agents,
pubmed-meshheading:11902729-Bacterial Proteins,
pubmed-meshheading:11902729-Drug Resistance, Bacterial,
pubmed-meshheading:11902729-Enterococcus,
pubmed-meshheading:11902729-Microbial Sensitivity Tests,
pubmed-meshheading:11902729-Mutation,
pubmed-meshheading:11902729-Peptide Synthases,
pubmed-meshheading:11902729-Teicoplanin,
pubmed-meshheading:11902729-Transduction, Genetic,
pubmed-meshheading:11902729-Vancomycin Resistance
|
pubmed:year |
1997
|
pubmed:articleTitle |
Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci.
|
pubmed:affiliation |
Unité des Agents Antibactériens, Centre National de la Recherche Scientifique EP J0058, Institut Pasteur, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|